Literature DB >> 1371227

Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes.

M Boulton1, P Moriarty, Z J Gregor.   

Abstract

This study compared the effects of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes on the proliferation and migration of retinal microvascular cells in vitro. Intraocular fluids were obtained from eyes undergoing repair of retinal detachment, due either to proliferative diabetic retinopathy or rhegmatogenous retinal detachment associated with a degree of proliferative vitreoretinopathy. The results demonstrated that the intraocular stimulatory activity for the proliferation of retinal microvascular endothelial cells varied between the different ocular compartments. The mitogenic and migrational activity in vitreous gel was greater than that of either the subretinal or retrohyaloid fluids of the same eye, and the activity of subretinal fluid was intermediate between that of the vitreous gel and the retrohyaloid fluid. There was no significant difference between the activities of the samples from diabetic and non-diabetic eyes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371227      PMCID: PMC504166          DOI: 10.1136/bjo.76.2.79

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Angiogenic factor in human ocular fluid.

Authors:  A Baird; F Culler; K L Jones; R Guillemin
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

2.  Presence of endothelial cell growth factor activity in normal and diabetic eyes.

Authors:  G A Lutty; C Chandler; A Bennett; C Fait; A Patz
Journal:  Curr Eye Res       Date:  1986-01       Impact factor: 2.424

3.  Insulin-like growth factors in vitreous. Studies in control and diabetic subjects with neovascularization.

Authors:  M Grant; B Russell; C Fitzgerald; T J Merimee
Journal:  Diabetes       Date:  1986-04       Impact factor: 9.461

4.  Extracellular modulating factors and the control of intraocular neovascularization. An overview.

Authors:  B M Glaser
Journal:  Arch Ophthalmol       Date:  1988-05

Review 5.  Fibroblast growth factors.

Authors:  A Baird; P A Walicke
Journal:  Br Med Bull       Date:  1989-04       Impact factor: 4.291

Review 6.  Vasoproliferative retinopathies: clinical, morphogenetic and modulatory aspects.

Authors:  M E Boulton; D McLeod; A Garner
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

7.  Endothelial cell-stimulating angiogenesis factor in vitreous from extraretinal neovascularizations.

Authors:  C M Taylor; R D Kissun; A M Schor; D McLeod; A Garner; J B Weiss
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-10       Impact factor: 4.799

8.  Growth of retinal capillary endothelia using pericyte conditioned medium.

Authors:  H C Wong; M Boulton; J Marshall; P Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-11       Impact factor: 4.799

9.  Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration.

Authors:  P A Campochiaro; J A Jerdan; B M Glaser; A Cardin; R G Michels
Journal:  Arch Ophthalmol       Date:  1985-09

10.  Inhibition of microvascular endothelial cell proliferation by vitreous following retinal scatter photocoagulation.

Authors:  A Singh; M Boulton; C Lane; J Forrester; J Gaal; D McLeod
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

  10 in total
  2 in total

1.  Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.

Authors:  M Boulton; Z Gregor; D McLeod; D Charteris; J Jarvis-Evans; P Moriarty; A Khaliq; D Foreman; D Allamby; B Bardsley
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

2.  Massive proliferation of lens epithelial remnants after Nd-YAG laser capsulotomy.

Authors:  N P Jones; D McLeod; M E Boulton
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.